Moreover, GATA2 expression is associated with more, rather than less, aggressive prostate cancer, with overexpression increasing metastatic capacity [65], while GATA3 is associated with less aggressive breast cancer and overexpression prevents metastasis [53]. This evidence concerns the gene GATA2 and breast cancer.